Skip to main content

and
  1. No Access

    Article

    Tumors evade immune cytotoxicity by altering the surface topology of NK cells

    The highly variable response rates to immunotherapies underscore our limited knowledge about how tumors can manipulate immune cells. Here the membrane topology of natural killer (NK) cells from patients with l...

    **aohu Zheng, Zhuanghao Hou, Yeben Qian, Yongwei Zhang, Quanwei Cui in Nature Immunology (2023)

  2. Article

    Open Access

    Macrophage-Derived MMP-9 and MMP-2 are Closely Related to the Rupture of the Fibrous Capsule of Hepatocellular Carcinoma Leading to Tumor Invasion

    Hepatocellular carcinoma (HCC) is an aggressive tumor with a poor clinical prognosis. Rupture of the fibrous capsule (FC) is a very important clinical phenomenon in the invasion and metastasis of HCC. FC is ma...

    Quanwei Cui, Xuben Wang, Yongwei Zhang, Yiqing Shen in Biological Procedures Online (2023)

  3. Article

    Open Access

    Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma

    Currently, systemic therapies for patients with advanced-stage hepatocellular carcinoma (HCC) rely mainly on systemic drugs. However, traditional systemic drugs have a high rate of serious adverse events, and ...

    Yongshun Zheng, Ran Jia, Jun Li, **aohe Tian, Yeben Qian in Journal of Nanobiotechnology (2022)

  4. Article

    Open Access

    A novel nomogram and risk classification system predicting the Ewing sarcoma: a population-based study

    Ewing sarcoma (ES) is a rare disease that lacks a prognostic prediction model. This study aims to develop a nomogram and risk classification system for estimating the probability of overall survival (OS) of pa...

    Yongshun Zheng, **sen Lu, Ziqiang Shuai, Zuomeng Wu, Yeben Qian in Scientific Reports (2022)

  5. Article

    Open Access

    Immune infiltrating cells in cholangiocarcinoma may become clinical diagnostic markers: based on bioinformatics analysis

    Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor originating from the secondary bile duct and its branch epithelium. Among primary liver tumors, the incidence of ICC is second only to hepatocellular ...

    Yongwei Zhang, Sihan Chen, Jun Li, Wei Dai in World Journal of Surgical Oncology (2021)

  6. Article

    Open Access

    The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression

    Accumulating data indicate caspase-1 (CASP1), one of the inflammatory caspases, promotes hepatocellular carcinoma (HCC) progression in tumor proliferation, invasion, EMT phenotype and sorafenib resistance. How...

    Jun Li, Yongwei Zhang, Ran Ruan, Wei He, Yeben Qian in Cell Death & Disease (2020)

  7. Article

    Open Access

    LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH1

    T cell receptor gamma locus antisense RNA 1 (TRG-AS1) has been reported to involve in the progression of glioblastoma, however the role and its underlying molecular mechanism in hepatocellular carcinoma (HCC) ...

    Xuehu Sun, Yeben Qian, **ngyu Wang, Rongge Cao, Jianlin Zhang in Cancer Cell International (2020)

  8. No Access

    Article

    Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance

    Natural killer (NK) cells have crucial roles in tumor surveillance. We found that tumor-infiltrating NK cells in human liver cancers had small, fragmented mitochondria in their cytoplasm, whereas liver NK cell...

    **aohu Zheng, Yeben Qian, Binqing Fu, Defeng Jiao, Yong Jiang in Nature Immunology (2019)

  9. No Access

    Article

    Choice between different operative techniques on cavernous hepatic hemangiomas

    To investigate the optimizing of operative techniques on cavernous hepatic hemangioma by comparing the effective of the two approaches (enucleation and hepatectomy).

    Long Wu, Yeben Qian in The Chinese-German Journal of Clinical Oncology (2008)